High circulating levels of the IGF-1R ligand IGF-1 can also activate IGF-1R signaling and is correlated with increased risk of prostate [43], ovarian [44], and breast cancer [45], as well as possibly second primary cancers [46]. The gene discussed is IGF1R; the disease is breast cancer.